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Summary. The present work describes two radiosynthetic
pathways to prepare homocysteine[75Se]selenolactone 1 start-
ing from n.c.a. [75Se]selenite 2. It was achieved either by
alkylation reaction of n.c.a. methyl[75Se]selenide 4 or by
hydrolysis of alkylated 1,3-dicyclohexyl[75Se]selenourea 11.
N.c.a. methyl[75Se]selenide 4 is available using sulfur as
non-isotopic carrier. However, the radiochemical yield of the
substitution of 2-tert.-butoxycarbonylamino-4-bromobutyric
acid ethylester 5 with n.c.a. methyl-[75Se]selenide is only
in the range of 15%–20%. Birch reduction of protected n.c.a.
[75Se]selenomethionine 6 formed leads to a RCY of 5%–10%
homocysteine[75Se]selenolactone 1.
Alternatively, the synthesis of homocysteine[75Se]seleno-
lactone 1 is possible by hydrolysis of the corresponding
[75Se]selenouronium salt 11 available by addition of 2-tert.-
butoxycarbonylamino-4-bromobutyric acid ethylester 5 to
1,3-dicyclohexyl[75Se]selenourea 10. A method was developed
for the synthesis of 1,3-dicyclohexyl[75Se]selenourea 10
by addition of c.a. [75Se]SeH2 to 1,3-dicyclohexyl-
carbodiimide, which leads to 20%–30% RCY of c.a.
homocysteine[75Se]selenolactone 1.
Introduction
Due to its analogous chemical properties, selenium can be
a suitable substitute for sulfur in thioamino acids, proteins
and sulfur containing pharmaceuticals. The nuclear pro-
perties of selenium-73, with a half-life of 7 h and positron
branching of 65% suggest that it is useful for in vivo medi-
cal application using positron emission tomography [1]. The
half-life of 73Se offers the possibility to label and study se-
lenated radiotracers with relatively slow pharmacokinetics
using PET. A disadvantage of selenium-73, however, is its
longer-lived daughter arsenic-73 which adds to the radia-
tion dose. Homocysteine[73Se]selenolactone shall be used as
a longer-lived alternative of [11C]homocysteine thiolactone,
which can only be obtained as racemic mixture due to the
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short half-life of carbon-11 [2]. [11C]Homocysteine thiolac-
tone was used as a sensitive indicator for ischemic myocar-
dial tissue [3], where an increased formation of adenosine
is due to the breakdown of adenine nucleotides. The accu-
mulation of adenosine in hypoxic cells can be detected by
an excess of homocysteine in presence of [11C]homocysteine
which leads to an increased formation of intracellular
S-adenosyl homocysteine catalyzed by the enzyme SAH hy-
drolase (cf. Scheme 1). In order to image regional cardiac
adenosine production by positron emission tomography, la-
belled homocysteine thiolactone is administered, which can
readily penetrate cell membranes and take part in the conver-
sion of adenosine into S-adenosyl-homocysteine. According
to the chemical homology of sulfur and selenium, it is the
aim to substitute sulfur by the positron emitter 73Se to get
a longer lived radiotracer, to test the possibility of enzy-
matic conversion of adenosine into [73Se]selenoadenosine
homocysteine for future radiopharmacological studies.
For convenience, all radiosyntheses described here were
performed using the longer lived selenium-75 (T1/2 =
120 d), which was generated via the 75As(p, n)75Se reaction,
yielding n.c.a. [75Se]selenite after thermochromatographic
separation [4].
Since homocysteine thiolactone can easily be prepared
by reductive demethylation of methionine [5], a method was
developed to produce [75Se]selenomethionine (2-amino-
4-(methyl[75Se]seleno)butyric acid), which can consecu-
tively be converted into the corresponding [75Se]seleno-
Scheme 1. Imaging of regional ischemia with 1-[11C]homocysteine
thiolactone [cf.3].
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lactone via demethylation. Labelling at the n.c.a. level was
desired regarding the possible toxicity of selenium com-
pounds. The first chemical synthesis of c.a. [75Se]seleno-
methionine was developed by Plenevaux et al. [6]. Elem-
ental radioselenium was transformed into methyl selenide
by methyl lithium, which reacts with L-2-amino-4-bromo-
butyric acid to give c.a. L-[75Se]selenomethionine. The ra-
diochemical yield was about 40%, with a reaction time of
2 h. The major drawback was the limitation of specific activ-
ity due to the unavoidable addition of selenium carrier.
Alternatively, since Basmadijan et al. [7] suggested the
formation of asymmetric c.a. [75Se]selenoethers via ba-
sic hydrolysis of [75Se]selenouronium salts, this synthetic




All chemicals were purchased from Aldrich (Steinheim, Ger-
many) and Fluka (Buchs, Switzerland) except 2-amino-4-
bromobutyric acid hydrobromide, which was obtained from
Acros Organics (Geel, Belgium). All chemicals were used
without further purification. 2-tert.-Butoxycarbonylamino-
4-bromobutyric acid ethylester 5 [8] and homo-cysteine se-
lenolactone 1 [9] were synthesized according to literature
methods. Their identity was confirmed by 1H and 13C NMR,
IR and mass spectra. All preparations were conducted under
an atmosphere of argon. Analytical radio-HPLC was per-
formed on a system consisting of a Knauer pump 6400 and
a Knauer UV/Vis photometer 3060 with a detector wave-
length of 220 nm. Sample injection was accomplished by
a Rheodyne-Injector block 7125. For measurement of ra-
dioactivity the outlet of the UV detector was connected to
a NaI(Tl) well type scintillation detector and the recorded
data was processed by the software system Raytest Ra-
mona MCS (Nuclear Interface, Münster, Germany). HPLC
of aliquots of selenomethionine and [75Se]selenomethionine
for determination of the specific activity was performed
using a Nucleosil 100-5 NH2 (250× 4 mm) column (CS-
Chromatographie Service, Langerwehe, Germany) with a mo-
bile phase of acetonitrile/0.04 M KH2PO4 (aq.) (77/23) at
a flow rate of 1.0 mL/min. Radio-TLC was performed on
Merck silica gel plates. The developed radiochromatograms
were measured on an Instant Imager(Packard).
Radiosyntheses
Production of [75Se]selenite
[75Se]Selenium was produced using 20 MeV protons at the
compact cyclotron CV-28 at the Forschungszentrum Jülich
GmbH via the 75As(p, n)75Se reaction on a Cu3As-target.
After thermochromatographic isolation and separation via
described procedures [4], n.c.a. selenium-75 is available in
its oxidized form as [75Se]SeO32− 2 in water.
Synthesis of homocysteine[75Se]selenolactone 1 via
methyl lithium
100µL of a 5% hydrochloric acid and 100µL of an aque-
ous solution of 30 mg (1.2 mmol) of sodium thiosulfate were
added to a solution of about 10µCi of n.c.a. [75Se]selenite 2.
The precipitate was centrifuged for 15 min. The water phase
was decanted and the sulfur matrix washed three times with
dry tetrahydrofuran. The dry sulfur matrix containing the
radioselenium 3 was weighed (∼ 6–7 mg (0.1–0.2 mmol)
sulfur). It was then transformed into a mixture of methyl-
sulfide 4a and methyl[75Se]selenide 4 by addition of methyl
lithium in the range of 0.05–0.1 mmol under an atmo-
sphere of argon and stirring for 15 min until a yellow to
white suspension of methyl sulfide appeared. The mix-
ture was transferred into a conical 5 mL reaction vessel
equipped with a magnetic stirring bar and a teflon-rubber
septum under an atmosphere of argon. Then 0.1 mmol
2-tert.-butoxycarbonylamino-4-bromobutyric acid ethyl-
ester 5 dissolved in 300 µL DMF was added and heated for
30 min. The products were isolated by chromatography on
a silica gel column (1×10 cm) using acetone as eluent. The
organic phase was evaporated to dryness under a stream of
argon.
A stream of ammonia was introduced into the re-
action vessel containing the dry residue. The flask was
cooled to about −40 ◦C in order to condense liquid am-
monia (2–4 mL). Elemental sodium (0.1–0.2 mmol) was
added to the solution while gaseous ammonia was contin-
uously led through the deep blue reaction mixture. After
15–20 min at −40 ◦C ammonium chloride was added to
destroy the sodium amide formed. Subsequently, the cool-
ing bath was removed and the liquid ammonia evaporated
by a gentle flow of argon followed by the addition 5 mL
of concentrated hydrochloric acid. For hydrolysis of pro-
tecting groups the solution was heated under reflux for
about 30 min in an inert atmosphere and evaporated to dry-
ness under a stream of argon. The residue was suspended
in ethanol and filtered over a Sep-PakC-18 cartridge
(Waters). Homocysteine[75Se]selenolactone 1 was analyzed
via radio-TLC with n-butanol/ethanol/formic acid 5/1/1
(v/v/v) as eluent.
Synthesis of homocysteine[75Se]selenolactone 1 via
[75Se]selenourea 10
The c.a. [75Se]selenouronium salt 11 was synthezised
by reaction of c.a. 1,3-dicyclohexyl[75 Se]selenourea 10
(0.1 mmol) (prepared via published methods [10]) with
2-tert.-butoxycarbonylamino-4-bromobutyric acid ethyl-
ester 5 (0.2 mmol) in acetonitrile (0.3 mL). The alkylation
reactions were monitored by radio-TLC (diethyl ether/
n-hexane 3/2 (v/v)). By-products and educts were removed
by column chromatography (10×1 cm) on silica gel using
diethyl ether and the purified [75Se]selenouronium salt 11
was eluted from the column with acetone.
Hydrolysis of the purified [75Se]selenouronium salts 11
with tetrabutylammonium hydroxide (0.1 mmol) in 2 mL
methanol was done within 5 min. After removal of the sol-
vent, 5 mL of concentrated hydrochloric acid was added
to the residue and heated for 30 min at 100 ◦C. The sol-
vent was removed, the residue was suspended in ethanol
and filtered over a Sep-PakC-18 cartridge (Waters).
Homocysteine[75Se]selenolactone 1 was analyzed on radio-
TLC with n-butanol/ethanol/formic acid 5/1/1 (v/v/v) as
eluent.
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Results and discussion
The first labelling method presented (cf. Scheme 2) is based
on the original chemical synthesis of c.a. [75Se]seleno-
methionine, described by Plenevaux et al. [6]. However,
the selenium carrier was substituted by elemental sulfur as
non-isotopic tracer. N.c.a. [75Se]selenite 2, obtained after
thermochromatographic isolation from the target [4], was re-
duced under acidic conditions with sodium thiosulfate lead-
ing to the precipitation of sulfur inserting more than 90% of
the n.c.a. 75Se in the elemental form, probably inserted as
[75Se]SeS8 rings. The sulfur matrix 3 containing the elemen-
tal [75Se]selenium prevents the rapid oxidation of the radio-
tracer. It was transformed with methyl lithium into a mixture
of lithium methyl [75Se]selenide 4 and lithium methyl mer-
captide 4a. The optimum amount of methyl lithium ranges
from 50 to 100% of the equimolar amount related to pre-
cipitated sulfur. An excess of methyl lithium should be
avoided in order to minimize side reactions, especially the
formation of volatile radioselenium products. Subsequent
reaction with 2-tert.-butoxycarbonylamino-4-butyric acid
ethylester 5 in DMF leads to the formation of n.c.a. 2-tert.-
butoxycarbonylamino-4-(methyl[75 Se]seleno)butyric acid
ethylester 6 and the corresponding methionine derivative 6a.
Fig. 1 shows the temperature dependence of the forma-
tion of n.c.a. 2-tert.-butoxycarbonylamino-4-(methyl[75 Se]-
seleno)butyric acid ethylester 6 which leads at 80 to 100 ◦C
to a 15 to 20% RCY after 30 min reaction time in DMF.
[75Se]Selenomethionine is available after hydrolysis of
2-tert.-butoxycarbonylamino-4-(methyl[75 Se]seleno)butyric
acid ethylester 6 with hydrochloric acid and can be separated
from methionine by HPLC analysis. The specific activity of
the n.c.a. product was > 185 GBq/mmol. For convenience it
was determined at the step of [75Se]selenomethionine since
isotopic dilution can be excluded during its conversion into
homocysteine[75Se]selenolactone 1.
The Birch reduction of the N-Boc-protected aminoacid
esters 6 and consecutive cleavage of the protection groups
under simultaneous lactonisation in presence of hydrochlo-
ric acid leads to the formation of n.c.a. homocysteine
Scheme 2. Radiosynthesis of non-isotopic carrier added homocysteine
[75Se]selenolactone 1 via methyl lithium.
Fig. 1. Temperature dependence of the formation of n.c.a. 2-tert.-
butoxycarbonylamino-4-(methyl[75Se]seleno)butyricethylester 6 start-
ing with Li[75Se]SeCH3. Reaction conditions: c(2-tert.-Butoxy-
carbonylamino-4-bromobutyric acid ethylester 5) = 0.5 mol/l, 0.2 ml
DMF, 0.2 ml THF, 80 ◦C, c(Sulfur) = 0.5 mol/l, c(MeLi)k = 0.25–
0.5 mol/l, reaction time: 30 min.
[75Se]selenolactone 1 with a radiochemical yield of 5%–10%
(related to n.c.a. [75Se]selenite) and natural homocysteine
thiolactone 1a within 180 min total synthesis time.
The major drawback of this method is the large loss
of volatile selenium activity (presumably dimethyl[75Se]-
selenide in the reaction with methyl lithium and correspond-
ing dimethylthio[75Se]selenide, respectively) and the forma-
tion of unknown side products.
An alternative radiosynthesis was developed starting with
the formation of selenouronium salts 11 (cf. Scheme 3).
1,3-Dicyclohexyl[75 Se]selenourea 10, a useful synthon to
produce [75Se]selenols via [75Se]selenouronium salts 11,
can be obtained by addition of hydrogen[75Se]selenide 8 to
1,3-dicyclohexylcarbodiimide 9 [10]. However, the forma-
tion of [75Se]SeH2 8 using hypophosphorous acid or stan-
nous chloride for reduction only takes place in presence of
carrier selenite. Accordingly, only c.a. selenoethers can be
obtained by this method. However, the alkylation step is
not limited to the synthesis of methylselenoethers like in
the previous procedure via Li[75Se]SeCH3 4 (also used by
Plenevaux et al. [6]).
The alkylation of c.a. 1,3-dicyclohexyl[75 Se]seleno-
urea 10 with 2-tert.-butoxycarbonylamino-4-bromobutyric
acid ethyl ester 5 in acetonitrile leads to a nearly quantitative
Scheme 3. Radiosynthesis of homocysteine[75Se]selenolactone 1 via
[75Se]selenourea.
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formation of the corresponding selenouronium salt 11,
which can be transformed in presence of tetrabutylam-
monium hydroxide and subsequent acidification with con-
centrated hydrochloric acid into homocysteine[75Se]seleno-
lactone 1. The total RCY starting from [75Se]selenite 2
is 20%–30%; the total synthesis time about 90 min. The
advantage of this strategy is its versatile application to
the synthesis of various asymmetric radioselenoethers. The
methods described recently for 75Se-labelling [6, 8] only
lead to methyl[75Se]selenoethers and do not offer the pos-
sibility to synthesize a broad variety of symmetric as
well as asymmetric [75Se]selenoethers. The radiosynthesis
of homocysteine[75Se]selenolactone 1 via the selenourea-
strategy is more convenient, because a Birch reduction,
which is not suitable for automated radiosyntheses, is
avoided. However, starting with hydrogen [75Se]selenide the
synthesis of 1,3-dicyclohexyl[75 Se]selenourea is so far only
possible in presence of hydrogen selenide carrier.
Conclusion
Radioselenoethers have been synthesized via two path-
ways, either by alkylation of n.c.a. methylselenide 2 or
by hydrolysis of alkylated dicyclohexyl[75 Se]selenourea 11.
N.c.a. methyl[75Se]selenide is available using sulfur as non-
isotopic carrier. This is necessary to enable labelling reac-
tions on the n.c.a. level. However, the radiochemical yield
is only in the range of 15%–20% within 60 min (related
to starting [75Se]selenite), because the formation of volatile
side products, probably dimethyl[75Se]selenide, could not be
avoided.
The synthesis of homocysteine[75Se]selenolactone 1 is
possible via Birch reduction of 2-tert.-butoxycarbonylamino-
4-(methyl[75Se]seleno)butyric acid ethylester 6 and subse-
quent hydrolysis and cyclisation using hydrochloric acid
leading to a RCY of 5%–10% of the title compound 1
within 180 min total synthesis time starting from n.c.a.
[75Se]selenite 2.
Alternatively, the synthesis of homocysteine[75Se]seleno-
lactone 1 is possible by hydrolysis of the correspond-
ing [75Se]selenouronium salt 11. The RCY of c.a. homo-
cysteine[75Se]selenolactone 1 via this route compared to the
previous one is three times higher with nearly half of the
reaction time because the demethylation step (Birch reduc-
tion) on [75Se]selenomethionine is avoided. Furthermore, no
volatile radio- selenium side products were observed. How-
ever, the choice of [75Se]SeH2 8 as starting material limits
the maximum possible specific activity since it can only be
formed in presence of carrier [10].
Nevertheless, in contrast to the recently described method
for n.c.a. 75Se-labelling via triphenylphosphine which only
provides methyl[75Se]selenoethers [8], the method via
1,3-dicyclohexyl[75 Se]selenourea 10 offers the possibility to
synthesize a broad variety of symmetric as well as asymmet-
ric [75Se]selenoethers.
In summary, the selenourea strategy is more convenient
for the synthesis of the title compound 1, because it results in
higher RCY, is easier to handle and offers the possibility of
automated radiosyntheses. With regard to potential toxicity
of selenium compounds, further studies have to be performed
in order to synthezise homocysteine [75Se]selenolactone 1
via n.c.a. [75Se]selenoureas starting from n.c.a. 75Se0 .
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